UAE Insulin Pumps Market to grow with a CAGR of 15.54%
Increasing
healthcare infrastructure and a supportive regulatory environment are the major
drivers for the UAE Insulin Pumps Market.
According
to TechSci Research report, “UAE Insulin Pumps Market Industry Size, Share,
Trends, Competition, Opportunity and Forecast, 2018-2028”, UAE Insulin Pumps Market has valued at USD 49.90 million in
2022 and is anticipated to witness an impressive growth in the forecast period
with a CAGR of 15.54% through 2028. This can be due to collaborations and
partnerships among leading companies with a diverse approach to merge the
expertise of individual companies and to strengthen their position in the
market. Improved access to healthcare is a key factor that can drive the demand
for insulin pumps. Improved access to healthcare services enables individuals
to receive early diagnosis and intervention for diabetes. In cases where
insulin pump therapy is deemed necessary, timely access to healthcare
facilities ensures that patients can start using insulin pumps at an early
stage of their condition. Healthcare facilities that specialize in diabetes
care, such as endocrinology clinics and diabetes centers, are better equipped
to provide comprehensive management solutions, including insulin pump therapy.
Improved access to these specialized services can increase the availability of
insulin pumps for patients who may benefit from them. Access to trained
healthcare professionals, such as endocrinologists, diabetes educators, and
specialized nurses, is crucial for the successful implementation of insulin
pump therapy. Improved access ensures that patients receive proper guidance,
training, and ongoing support from knowledgeable professionals.
Access
to healthcare facilitates educational initiatives on diabetes management,
including the benefits of insulin pumps. Healthcare providers can disseminate
information about insulin pump therapy, leading to greater awareness and
potentially increased demand among patients who were previously unaware of this
treatment option. Improved access to healthcare often involves efforts to
enhance insurance coverage and reimbursement policies for medical devices,
including insulin pumps. When patients have better financial support for
acquiring insulin pumps, it can significantly boost the demand for these
devices. Geographic and economic barriers to healthcare can be significant
obstacles for some individuals. Improved access may involve efforts to reduce
these barriers, making it easier for patients to reach healthcare facilities
where they can receive information about and access insulin pumps.
Browse
over XX market data Figures and spread through XX
Pages and an in-depth TOC on " UAE Insulin Pumps Market.”
In February 2023, GulfDrug LLC, EOFlow Co.'s
partner in the Gulf region, has introduced the tubeless, disposable insulin
pump "EOPatch" in the United Arab Emirates (UAE). Starting from
February 2023, residents in the UAE can manage insulin infusions directly from
their Android and iOS smartphones through the newly launched Narsha app. This
marks the first entry of EOPatches in the Middle East, establishing the UAE as
EOFlow's second overseas sales region, following Europe. The launch is seen as
a strategic move, serving as a gateway for exporting wearable insulin pump
solutions to Middle East and North Africa (MENA) countries. GulfDrug is
actively preparing to extend its presence to other Gulf countries and plans to
seek approval and registration for EOPatch in Saudi Arabia, the largest
diabetes market in the Gulf Cooperation Council (GCC) countries. EOFlow and
GulfDrug are committed to expanding their market presence in the Gulf region,
given the significant diabetes population in the area. EOPatch is notable as
one of the two fully disposable, wearable insulin pump solutions currently
available worldwide.
Data
privacy concerns are a significant challenge in the UAE insulin pumps market,
as in many other healthcare technology sectors. Insulin pumps, especially those
integrated with digital health platforms, collect and store sensitive health
information, including real-time glucose levels and insulin dosages. The
protection of this highly personal data is paramount to maintain patient trust.
The UAE, like many other countries, has regulations and standards governing the
protection of healthcare data. Ensuring compliance with these regulations, such
as the Health Data Protection Law, is essential but can be challenging due to
the evolving nature of digital health technologies. The interconnected nature
of digital health devices, including insulin pumps, makes them susceptible to
cybersecurity threats. Unauthorized access to patient data can lead to privacy
breaches, identity theft, and other malicious activities. Patients may be
hesitant to adopt insulin pumps if they are concerned about the confidentiality
of their health information. The fear of unauthorized access to personal health
data can create barriers to adoption.
UAE Insulin Pumps Market is segmented based on Type,
Insulin Used, Application, End User, and by region.
Based on the Type, UAE Insulin Pumps Market is
segmented into Traditional Insulin Pumps, Patch Pumps. Traditional insulin
pumps, also known as conventional insulin pumps, are medical devices designed
to deliver a continuous and precise supply of insulin to individuals with
diabetes. These pumps provide an alternative to multiple daily injections,
offering a more automated and controlled approach to insulin delivery. Traditional insulin pumps deliver a
continuous and low-level supply of insulin throughout the day and night. This
background insulin, known as the basal rate, mimics the natural secretion of
insulin by the pancreas and helps maintain stable blood glucose levels between
meals and during periods of fasting. In addition to basal insulin, traditional
insulin pumps allow users to administer additional insulin as needed. This
additional insulin, known as a bolus, is delivered to cover meals or correct
high blood glucose levels. Users manually input the bolus amount based on
factors such as carbohydrate intake and current blood glucose levels.
Based on Region, Abu Dhabi region held the largest share in the UAE Insulin
Pumps Market. Economic factors, such as higher income levels in Abu Dhabi,
could influence the affordability and accessibility of insulin pumps. Patients
in regions with higher income levels may be more likely to afford these
devices. Abu Dhabi is a hub for medical research and innovation, it could
attract companies and professionals working on the development and promotion of
advanced diabetes management technologies, including insulin pumps. The
prevalence of diabetes in a region's population could also impact the demand
for insulin pumps. If the Abu Dhabi population has a higher incidence of
diabetes, there may be a greater need for advanced diabetes management
solutions.
Some of the major companies
operating in the UAE Insulin Pumps
Market include:
- Medtronic
Meta FZ-LLC
- Roche
UAE
- Abbott
Laboratories, S.A.
- Nipro
Middle East FZE
- B.
Braun Medical Gulf Fz-LLC
- Terumo
Middle East FZE
- Becton,
Dickinson, and Company
Download Free Sample Report
Customers can also request 10% free customization on this report.
“Certain areas, particularly in Dubai, are projected
to exert significant demand for Insulin Pumps. The growth in the competitive
landscape and the presence of well-established companies in the market, committed
to enhance the overall wellbeing of people each year, are expected to
contribute to a remarkable growth of the UAE Insulin Pumps Market in the
forecast period," said Mr. Karan Chechi, Research Director with TechSci
Research, a research-based Global management consulting firm.
UAE Insulin Pumps Market by Type
(Traditional Insulin Pumps, Patch Pumps), By Insulin Used (Short Acting
Insulin, Rapid Acting Insulin), By Application (Type 1 Diabetes, Type 2
Diabetes), By End User (Hospitals & Clinics, Diagnostic Centers, Home Care),
By Region, By Competition Forecast &
Opportunities, 2018-2028F has
evaluated the future growth potential of UAE Insulin Pumps Market and
provides statistics & information on market size, structure, and future
market growth. The report intends to provide innovative market intelligence and
help decision makers take sound investment decisions. Besides, the report also
identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in UAE Insulin Pumps Market.
Contact
Techsci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel:
+13322586602
Email:
[email protected]
Website:
www.techsciresearch.com